# Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.

> **NCT06355843** · NA · SUSPENDED · sponsor: **The First Affiliated Hospital of Anhui Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer
- Pet-ct

## Interventions

- **DRUG:** 68Ga-PSMA

## Key facts

- **NCT ID:** NCT06355843
- **Lead sponsor:** The First Affiliated Hospital of Anhui Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2022-04-28
- **Primary completion:** 2023-09-30
- **Final completion:** 2027-03-31
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** The 68Ge/68Ga generator is currently at the end of its lifespan. We are trying to purchase new equipment, which will take about half a year.
- **Last updated:** 2024-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06355843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06355843, "Clinical Applications of Integrated PET/MR and PET/CT in the Diagnosis and Treatment of Prostate Cancer.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06355843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*